Advanced search
Start date
Betweenand
(Reference retrieved automatically from SciELO through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Myocardial perfusion study and coronary artery angiography in systemic lupus erythematosus patients

Full text
Author(s):
Elaine Marcelina Claudio Sella ; Emilia Inoue Sato [2]
Total Authors: 2
Document type: Journal article
Source: REVISTA BRASILEIRA DE REUMATOLOGIA; v. 44, n. 4, p. 259-267, 2004-08-00.
Abstract

OBJECTIVE: To evaluate coronary artery findings using coronary artery angiography in systemic lupus erythematosus (SLE) patients with myocardial perfusion abnormalities. METHODS: Ninety female SLE patients, ages from 18 to 55 years old, more than 5 years of disease duration, without current or previous confirmed coronary artery disease (CAD), and who were either in use or had used steroid treatment for at least 1 year were evaluated. Myocardial perfusion scintigraphy was performed using a singlephoton emission computed tomography employing Technetium 99m-sestamibi. Images were captured at resting and after dipyridamole-induced stress. The CAD risk factors (RF) considered were the traditional ones in general population and SLE-related factors. All patients who had abnormal findings on myocardial perfusion tests were invited to undergo coronary angiography. RESULTS: The mean age was 38 ± 10 years old, with mean disease duration of 128 ± 59 months, American College of Rheumatology (ACR) number 7 ± 1, Disease Activity Index for SLE (SLE-DAI) score 6 ± 5 and Systemic Lupus International Collaborating Clinics/ACR Damage Index for SLE (SLICC/ACR-DI) score 2 ± 2. Thirty-three percent of patients presented myocardial perfusion scintigraphy abnormalities. Regression logistic analysis was performed considering the traditional CAD-RF and SLE-related variables in 48 SLE patients on regular follow-up. Current vasculitis was associated with abnormal myocardial perfusion. There was no association between other clinical and/or serologic features, cumulative dose or duration of prednisone use and myocardial perfusion scintigraphy results. Twenty-one patients with abnormal myocardial scintigraphy agreed to undergo coronary angiography. Atherosclerotic plaques were identified by angiography in eight patients (38%). Abnormal angiography subgroup presented higher number of traditional CAD-RF (p = 0.006). Arterial hypertension, postmenopausal status and higher triglyceride level showed a significant association with abnormal angiography (p = 0.046, 0.024 and 0.043, respectively). The number of ACR criteria, SLE-DAI and SLICC/ACR-DI scores were also higher in the sub-group with coronary abnormalities (p = 0.018, 0.010 and 0.003, respectively). CONCLUSIONS: Current vasculitis was an important variable associated with abnormal myocardial scintigraphy. This study suggests that myocardial scintigraphy can be used as a screening test for CAD in SLE patients with high-risk of cardiovascular disease, even in the absence of ischemic heart symptoms. Patients with abnormal myocardial perfusion results and at least four CAD-RF had higher risk of presenting coronary stenosis on coronary angiography. (AU)